300942 Stock Overview
Develops and sells rapid testing instruments and reagents in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Shenzhen Bioeasy Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.52 |
| 52 Week High | CN¥11.42 |
| 52 Week Low | CN¥5.67 |
| Beta | 0.62 |
| 1 Month Change | 15.67% |
| 3 Month Change | 9.30% |
| 1 Year Change | 24.12% |
| 3 Year Change | -56.17% |
| 5 Year Change | n/a |
| Change since IPO | -73.58% |
Recent News & Updates
Recent updates
Is Shenzhen Bioeasy Biotechnology (SZSE:300942) A Risky Investment?
Mar 19
Shenzhen Bioeasy Biotechnology Co., Ltd.'s (SZSE:300942) 26% Price Boost Is Out Of Tune With Revenues
Nov 27Shenzhen Bioeasy Biotechnology Co., Ltd.'s (SZSE:300942) 28% Price Boost Is Out Of Tune With Revenues
Sep 30Subdued Growth No Barrier To Shenzhen Bioeasy Biotechnology Co., Ltd.'s (SZSE:300942) Price
Jun 26Shenzhen Bioeasy Biotechnology Co., Ltd. (SZSE:300942) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Mar 08Shareholder Returns
| 300942 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 1.4% | -0.4% | -0.4% |
| 1Y | 24.1% | -11.2% | 7.2% |
Return vs Industry: 300942 exceeded the CN Medical Equipment industry which returned -11.2% over the past year.
Return vs Market: 300942 exceeded the CN Market which returned 7.2% over the past year.
Price Volatility
| 300942 volatility | |
|---|---|
| 300942 Average Weekly Movement | 9.1% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in CN Market | 10.3% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 300942's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300942's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 480 | Zhaoli Xiao | www.bioeasy.com |
Shenzhen Bioeasy Biotechnology Co., Ltd. develops and sells rapid testing instruments and reagents in China. The company offers cereals and feed, milk antibiotic, meat and seafood, honey antibiotic, and pesticides rapid test kits. It also offers veterinary, coronavirus, and DNA / RNA extraction kits, as well as provides drug of abuse screening tests.
Shenzhen Bioeasy Biotechnology Co., Ltd. Fundamentals Summary
| 300942 fundamental statistics | |
|---|---|
| Market cap | CN¥3.82b |
| Earnings (TTM) | CN¥20.88m |
| Revenue (TTM) | CN¥237.12m |
Is 300942 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300942 income statement (TTM) | |
|---|---|
| Revenue | CN¥237.12m |
| Cost of Revenue | CN¥82.39m |
| Gross Profit | CN¥154.73m |
| Other Expenses | CN¥133.85m |
| Earnings | CN¥20.88m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.052 |
| Gross Margin | 65.25% |
| Net Profit Margin | 8.81% |
| Debt/Equity Ratio | 54.9% |
How did 300942 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 02:32 |
| End of Day Share Price | 2025/05/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shenzhen Bioeasy Biotechnology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.